Table 2.

Simple main effects of fear conditioning for direct gaze faces (CSdg+ > CSdg) in the placebo and oxytocin groups

Placebo groupOxytocin groupDifference placebo versus oxytocin group
Coordinatest valuep valueCoordinatest valuep valueCoordinatest valuep value
Amy20, 0, −182.63NS18, 2, −203.450.05*
Amy−14, −8, −222.65NS
R Insula40, 32, −83.30NS
L Insula
cACC16, 10, 523.95<0.00116, 2, 364.48<0.00114, 8, 464.01<0.001
cACC−16, 10, 463.500.001−16, 10, 443.58<0.001
subgACC14, 44, −84.20<0.001
vlPFC48, 48, 43.89<0.00148, 48, 44.73<0.001
vlPFC−50, 32, 104.72<0.001−50, 32, 6−5.01<0.001
mObfc18, 54, −64.60<0.001
R FFA36, −54, −124.47<0.00138, −54, −123.71<0.001
  • Amy, Amygdala; cACC, caudal anterior cingulate cortex; subgACC, subgenual ACC; vlPFC, ventrolateral prefrontal cortex; mObfc, medial orbitofrontal cortex; FFA, fusiform face area; R, right; L, left; NS, nonsignificant. *Small volume corrected.